Posted on July 8, 2009 by Patients and Patents
The World Health Organization reports that a clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, [...]
Filed under: Africa, Public health, World Health Organization | Tagged: Innovation, neglected diseases, World Health Organization | Leave a Comment »
Posted on June 18, 2009 by Patients and Patents
A landmark collaboration could see the development of the first new-action tuberculosis drug in 40 years. Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership, and Tibotec, a Johnson & Johnson company, have joined forces to focus on the development of the new experimental drug TMC207.
Forbes reports that if the drug [...]
Filed under: Innovation, Public health | Tagged: drug development, Innovation, tuberculosis, World Health Organization | Leave a Comment »
Posted on May 20, 2009 by Patients and Patents
Live Twitter updates from the 62nd World Health Assembly: www.twitter.com/patientspatents
Discussions on issues of public health and innovation have been further delayed. They were to be discussed yesterday, but have been rescheduled for later today. With other issues such as climate change, social determinants of health and pandemic influenza preparedness also on the agenda, it seems likely [...]
Filed under: World Health Organization | Tagged: IGWG, Innovation, World Health Assembly, World Health Organization | Leave a Comment »
Posted on May 20, 2009 by Patients and Patents
WHO Director-General Dr Margaret Chan and United Nations Secretary-General Ban Ki-moon met with over 30 vaccine manufacturers from developing and developed countries at WHO headquarters yesterday. Industry representatives affirmed their wish to cooperate in making supplies of any eventual vaccine for Influenza A(H1N1) available to developing countries, and said they stood ready to produce the [...]
Filed under: Public health, World Health Organization | Tagged: drug development, H1N1, Innovation, vaccine, World Health Organization | 1 Comment »
Posted on May 19, 2009 by Patients and Patents
Live Twitter updates from the 62nd World Health Assembly: www.twitter.com/patientspatents
The 62nd World Health Assembly opened yesterday (May 18, 2009) and much of the administrative details (election of the President, chairmans of the committees, adoption of the agenda, etc.). Dr. Margaret Chan also addressed the Assembly.
The WHA was significantly shortened due to the H1N1 outbreak. As a [...]
Filed under: Public health, World Health Organization | Tagged: H1N1, World Health Assembly, World Health Organization | Leave a Comment »
Posted on March 26, 2009 by Patients and Patents
The World Health Organization released its’ thirteenth report on Tuberculosis control this week, which provides information and statistics related to the numbers of cases and numbers of deaths due to TB in 196 countries. The report stresses the link between HIV and TB, suggesting that roughly 25% of people who died from TB in 2007 were [...]
Filed under: Public health | Tagged: neglected diseases, Public health, tuberculosis, World Health Organization | 1 Comment »
GAVI announces innovative approach to developing vaccines for developing nations
At the end of last week, the GAVI Alliance partners (the World Bank, WHO and UNICEF), five national governments and the Bill & Melinda Gates Foundation formally announced the first-ever Advance Market Commitment (AMC) designed to accelerate access to vaccines against pneumococcal disease.
The Wall Street Journal reports that the $1.5 billion program marks a departure [...]
Filed under: Commentary on news & events, Innovation, Public health | Tagged: access to medicines, Bill & Melinda Gates Foundation, GAVI Alliance, Innovation, vaccine, World Health Organization | Leave a Comment »